{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:52:37Z","timestamp":1791971557295,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023331","name":"LEO Pharma A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xjidi.2026.100541","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:31:47Z","timestamp":1789972307000},"page":"100541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcipotriol-betamethasone foam modulates serum and tissue IL-17A, IL-31, IL-31RA, and substance P in mild-to-moderate psoriatic itch: A clinical and immunopathological study"],"prefix":"10.1016","volume":"6","author":[{"given":"Irene","family":"Bonanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Del Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magnatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Biancamaria","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ruffo di Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Corr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Coi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Della Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Verdelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Caproni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2026.100541_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2230.1995.tb01354.x","article-title":"Neuropeptides and general neuronal marker in psoriasis\u2014an immunohistochemical study","volume":"20","author":"Al\u2019Abadie","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10241.x","article-title":"Expression of tachykinins and their receptors in plaque psoriasis with pruritus","volume":"164","author":"Amatya","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000270385","article-title":"Responses to intradermal injections of substance P in psoriasis patients with pruritus","volume":"23","author":"Amatya","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.xjidi.2026.100541_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.1991.tb04948.x","article-title":"Neuropeptides in skin disease: Increased VIP in eczema and psoriasis but not axillary hyperhidrosis","volume":"124","author":"Anand","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.xjidi.2026.100541_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaad.2018.07.058","article-title":"Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA","volume":"79","author":"Aschenbeck","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1590\/abd1806-4841.20175402","article-title":"The relationship between pruritus and clinical variables in patients with psoriasis","volume":"92","author":"Bahali","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420907186","article-title":"A potential inflammatory role of IL-31 in psoriatic arthritis: A correlation with Th17 cytokine profile","volume":"34","author":"Bautista-Herrera","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.xjidi.2026.100541_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cei.13140","article-title":"Synergistic effect of interleukin-17 and tumour necrosis factor-\u03b1 on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways","volume":"193","author":"Beringer","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2005.10.046","article-title":"IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis","volume":"117","author":"Bilsborough","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","article-title":"Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: A randomized-controlled trial","volume":"29","author":"Caproni","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s004030050249","article-title":"Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis","volume":"289","author":"Chan","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","article-title":"Neuropeptides and their receptors in psoriatic skin in relation to pruritus","volume":"156","author":"Chang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05621","article-title":"Increased serum IL-31 levels in chronic spontaneous urticaria and psoriasis with pruritic symptoms","volume":"6","author":"Chaowattanapanit","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.xjidi.2026.100541_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ced.12845","article-title":"Circulating T-helper 17 cells and associated cytokines in psoriasis","volume":"41","author":"Chhabra","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2133.2010.09992.x","article-title":"Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy","volume":"163","author":"Coimbra","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2133.2011.10487.x","article-title":"Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells","volume":"165","author":"Cornelissen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.5114\/pdia.2015.56097","article-title":"Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations","volume":"32","author":"Czarnecka-Operacz","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.xjidi.2026.100541_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jdv.15539","article-title":"Pruritus characteristics in a Large Italian cohort of psoriatic patients","volume":"33","author":"Damiani","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2340\/00015555-3112","article-title":"A Cost-utility Analysis of calcipotriol\/betamethasone dipropionate Aerosol Foam versus Ointment for the Topical Treatment of psoriasis vulgaris in Sweden","volume":"99","author":"Duvetorp","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2017.03.035","article-title":"The antimicrobial peptide human beta-defensin 2 promotes itch through toll-like receptor 4 signaling in mice","volume":"140","author":"Feng","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/oxfordjournals.bmb.a072189","article-title":"Peptides and neurogenic inflammation","volume":"43","author":"Foreman","year":"1987","journal-title":"Br Med Bull"},{"key":"10.1016\/j.xjidi.2026.100541_bib27","first-page":"238","article-title":"Severe psoriasis\u2014oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.xjidi.2026.100541_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.xjidi.2026.100541_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5507\/bp.2023.043","article-title":"Serum concentrations of 25-OH vitamin D and the pro-inflammatory interleukins IL-17, IL-23, and IL-18 in patients with plaque psoriasis","volume":"168","author":"Ganeva","year":"2024","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.xjidi.2026.100541_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1684\/ejd.2019.3581","article-title":"Pruritus and skin pain in psoriatic patients: The neglected symptoms","volume":"29","author":"Garc\u00eda-Fern\u00e1ndez","year":"2019","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"Germ\u00e1n","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.xjidi.2026.100541_bib32","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/exd.14657","article-title":"Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis","volume":"31","author":"Heim","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jdv.15393","article-title":"Itch relief in patients with psoriasis: Effectiveness of calcipotriol plus betamethasone dipropionate foam","volume":"33","author":"Jalili","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/ijd.12074","article-title":"Clinical and psychological characteristics of patients with psoriasis reporting various frequencies of pruritus","volume":"53","author":"Janowski","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib35","first-page":"623","article-title":"Characteristics of pruritus in various clinical variants of psoriasis: Results of the multinational, multicenter, cross-sectional study","volume":"11","author":"Jaworecka","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.xjidi.2026.100541_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.1998.00533.x","article-title":"Double-labeled immunofluorescence study of cutaneous nerves in psoriasis","volume":"37","author":"Jiang","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib38","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib39","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1097\/MS9.0000000000000948","article-title":"Prevalence and clinical characteristics of pruritus, and the factors significantly associated with high pruritic intensity in patients with psoriasis: A cross-sectional study","volume":"85","author":"Junsuwan","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.xjidi.2026.100541_bib40","article-title":"Interleukin-31 as a clinical target for pruritus treatment","volume":"8","author":"Kabashima","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xjidi.2026.100541_bib41","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.3390\/jcm13133895","article-title":"Plasma cytokines for the prediction of the effectiveness of TNF\u03b1 inhibitors etanercept, infliximab, and adalimumab in the treatment of psoriasis","volume":"13","author":"Karamova","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.xjidi.2026.100541_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5021\/ad.2014.26.6.727","article-title":"Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density","volume":"26","author":"Kim","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2340\/00015555-2801","article-title":"Long-term impact of Ixekizumab on psoriasis itch severity: Results from a Phase III clinical trial and long-term extension","volume":"98","author":"Kimball","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/09546634.2015.1083935","article-title":"Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris\u2014A randomized phase II study","volume":"27","author":"Koo","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.xjidi.2026.100541_bib46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/00015555-2579","article-title":"Clinical efficiency of topical calcipotriol\/betamethasone treatment in psoriasis relies on suppression of the inflammatory TNF\u03b1 - il-23 - IL-17 axis","volume":"97","author":"Kubin","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib47","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/itx.0000000000000041","article-title":"Sex differences in the perception of itch and quality of life in patients with chronic pruritus in the United States","volume":"5","author":"Kursewicz","year":"2020","journal-title":"Itch"},{"key":"10.1016\/j.xjidi.2026.100541_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/467541","article-title":"Serum levels of TNF-\u03b1, IL-12\/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity","volume":"2014","author":"Kyriakou","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib49","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2147\/CCID.S462446","article-title":"Inhibitory effect of evodiamine on psoriasis lesions and itching in mice","volume":"17","author":"Liang","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2015.12.009","article-title":"Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis","volume":"81","author":"Lovato","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.xjidi.2026.100541_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2133.2006.07736.x","article-title":"Itch Severity Scale: A self-report instrument for the measurement of pruritus severity","volume":"156","author":"Majeski","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.lpm.2019.02.016","article-title":"Factors predicting pruritus in psoriasis","volume":"48","author":"Mansouri","year":"2019","journal-title":"Presse Med"},{"key":"10.1016\/j.xjidi.2026.100541_bib53","first-page":"827","article-title":"Predicting factors and clinical characteristics of pruritus in psoriasis: A cross-sectional survey","volume":"14","author":"Morariu","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.xjidi.2026.100541_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","article-title":"Participation of interleukin 17A in neuroimmune interactions","volume":"41","author":"Moynes","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.xjidi.2026.100541_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00403-020-02066-1","article-title":"Gender differences in psoriasis: A Swiss online psoriasis survey","volume":"313","author":"Murer","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-012-1293-6","article-title":"Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients","volume":"305","author":"Narbutt","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00371834","article-title":"Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions","volume":"285","author":"Naukkarinen","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1523-1747.ep13071340","article-title":"Quantification of cutaneous sensory nerves and their substance P content in psoriasis","volume":"92","author":"Naukkarinen","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib60","article-title":"Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: A cross-sectional study in Vietnam","volume":"17","author":"Nguyen","year":"2025","journal-title":"Dermatol Reports"},{"key":"10.1016\/j.xjidi.2026.100541_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jdv.13859","article-title":"Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: Randomized, controlled PSO-ABLE study","volume":"31","author":"Paul","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12365423","article-title":"Autoradiographic detection of substance P receptors in normal and psoriatic skin","volume":"101","author":"Pincelli","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09546634.2019.1572865","article-title":"Psoriasis-associated itch: Etiology, assessment, impact, and management","volume":"31","author":"Pithadia","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.xjidi.2026.100541_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CCID.S4465","article-title":"Itch in psoriasis: Epidemiology, clinical aspects and treatment options","volume":"2","author":"Prignano","year":"2009","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5114\/ada.2021.108926","article-title":"Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus","volume":"38","author":"Purzycka-Bohdan","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.xjidi.2026.100541_bib66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","article-title":"Visual analogue scale: Evaluation of the instrument for the assessment of pruritus","volume":"92","author":"Reich","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-0851","article-title":"Pruritus is an important factor negatively influencing the well-being of psoriatic patients","volume":"90","author":"Reich","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/00015555-0265","article-title":"Plasma neuropeptides and perception of pruritus in psoriasis","volume":"87","author":"Reich","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.xjidi.2026.100541_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.12710","article-title":"Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis","volume":"24","author":"Reich","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00403-007-0745-x","article-title":"Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus","volume":"299","author":"Remr\u00f6d","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2133.2004.06093.x","article-title":"Prevalence of symptoms experienced by patients with different clinical types of psoriasis","volume":"151","author":"Sampogna","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib72","first-page":"367","article-title":"Comparing the clinical response and patient satisfaction of foam versus cream calcipotriol-betamethasone dipropionate treatment of localized plaque psoriasis","volume":"161","author":"Scribani Rossi","year":"2026","journal-title":"Ital J Dermatol Venerol"},{"key":"10.1016\/j.xjidi.2026.100541_bib73","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1208\/s12248-017-0094-4","article-title":"Ultra-sensitive measurement of IL-17A and IL-17F in psoriasis patient serum and skin","volume":"19","author":"Soderstrom","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.xjidi.2026.100541_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: A new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib75","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/bjd.12267","article-title":"Gender differences in chronic pruritus: Women present different morbidity, more scratch lesions and higher burden","volume":"168","author":"St\u00e4nder","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000028051","article-title":"Expression of substance P receptors in normal and psoriatic skin","volume":"67","author":"Staniek","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.xjidi.2026.100541_bib77","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1365-2133.2004.06299.x","article-title":"Pruritus and psoriasis","volume":"151","author":"Szepietowski","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/1346-8138.15155","article-title":"Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis","volume":"47","author":"Takeoka","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjd.20090","article-title":"Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways","volume":"185","author":"Tollenaere","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib81","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17C reduces skin inflammation in mouse models of psoriasis and atopic dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib82","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.xjidi.2026.100541_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156531","article-title":"Increased tissue expression of IL-31 in patients with psoriasis","volume":"176","author":"Wongjirattikarn","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.xjidi.2026.100541_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6092808","article-title":"Evaluation of serum proinflammatory cytokine IL-17A and tight junction protein Claudin-1 in psoriasis","volume":"2022","author":"Xu","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.xjidi.2026.100541_bib85","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00403-012-1229-1","article-title":"Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis","volume":"304","author":"Yilmaz","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.xjidi.2026.100541_bib86","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","article-title":"The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis","volume":"143","author":"Yosipovitch","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100541_bib87","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jaci.2019.01.013","article-title":"Beta-defensins are proinflammatory pruritogens that activate Mrgprs","volume":"143","author":"Zhang","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:25:02Z","timestamp":1791969902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026726000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2667026726000962"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100541","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcipotriol-betamethasone foam modulates serum and tissue IL-17A, IL-31, IL-31RA, and substance P in mild-to-moderate psoriatic itch: A clinical and immunopathological study","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100541"}}